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N-terminally truncated forms of chicken egg white cystatin and itscyanogen bromide fragments were isolated and assayed 
for inhibition of papain. Truncated forms beginning with Gly-9 and Ala-10 had a 5000-fold ower affinity for papain 
than the two isoelectric forms (pi=6.5 and 5.6) of the full-length in ibitor (K~--6 pM and 7 pM) or a truncated form 
beginning with Leu-7 (/~ = 6 pM), indicating the outstanding importance of ne or two residues preceding conserved 
Gly-9 for binding. A weak inhibition of papain (K~ = 900 nM) was exhibited by the intermediate cyanogen bromide frag- 
ment (residues 30-89) containing the chicken cystatin QLVSG variation of the QWAG segment which is conserved in 
almost all members ofthe cystatin superfamily. The obtained affinity data provide independent evidence for the validity 
of the proposed docking model of a chicken cystatin-papain complex [(1988) EMBO J. 7, 2593-2599]. 
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1. INTRODUCTION 
Chicken egg white cystatin belongs to family 2 
of the cystatin superfamily comprising various 
protein inhibitors of cysteine proteinases (reviews 
[1,2]). It forms a tight, reversible 1 : 1 complex with 
most known cysteine proteinases [3]. Chicken egg 
white cystatin has been reported to ccur in two 
major isoelectric forms, form 1 (pI = 6.5) and 
form 2 (pl = 5.6), which can be separated by ion 
exchange chromatography [4,5]. Both forms repre- 
sent the full-length inhibitors starting with Ser 
(Ser-form) and comprising 116 amino acid residues 
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[4,6]. Also shorter forms starting with Gly-9 (Gly- 
form) and Ala-10 (Ala-form) have been found 
[4,7]. The Ala-form was shown to be a 10000-fold 
weaker inhibitor of papain [7]. 
Recently we have proposed a model for the in- 
teraction of cystatins with cysteine proteinases 
based on the X-ray crystal structure of the Gly- 
form of chicken egg white cystatin and subsequent 
docking experiments [8]. Three parts of the in- 
hibitor are in close contact with the active site cleft 
of papain: the amino terminus, a first hairpin loop 
(residues 53-57) containing the chicken cystatin 
QLVSG variation of the prototype sequence 
QVVAG conserved in almost all members of the 
cystatin superfamily [1,2] and a second hairpin 
loop (residues 102-107) containing the conserved 
Trp-104. According to the docking model, Leu-8 
of chicken cystatin was predicted to interact 
specifically with the Sz-subsite of papain raising 
the question which residues preceding Ala-10 are 
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the most important for the increased inhibitory af- 
finity of the full-length form. 
In this paper we describe further separation of 
isoelectric forms 1 and 2 of chicken cystatin by 
hydrophobic interaction chromatography. Using 
this method, we were able to separate up to four 
components of each isoelectric form differing in 
the length of the amino terminus. Furthermore, 
peptide fragments of chicken cystatin were 
prepared by cyanogen bromide cleavage. The 
estimated inhibition constants for the interaction 
of the N-terminally truncated forms and the pep- 
tide fragments with papain support he proposed 
mechanism of inhibition. 
2. MATERIALS AND METHODS 
2.1. Materials 
Chicken egg white cystatin was isolated as described [4]. Pa- 
pain (EC 3.4.22.2, from papaya latex, type III, Sigma) was 
repurified by covalent chromatography on an agarose mercurial 
column [9] leading to a 96070 active enzyme as determined by 
titration with E-64 [10]. 
2.2. Isolation o f  inhibitor forms and fragments 
Ion exchange chromatography of the crude inhibitor was per- 
formed on a Mono Q FPLC column (Pharmacia) with a 
0-0.5 M KC1 gradient in 20 mM Tris-HCI, pH 8.0. The pooled 
peak fractions were adjusted to 0.5 M (NI-h)2SO4 and loaded 
on a Bio Gel Phenyl-5PW column (Bio Rad). Hydrophobic in- 
teraction chromatography on this column was done in 0.1 M 
potassium phosphate buffer, pH 7.0, using a gradient of 
decreasing (NH4)~SO4 concentration from 0.5-0 M at a flow 
rate of 1.0 ml/min. 
Limited proteolysis of chicken cystatin was performed by in- 
cubation of the Ser-form 1 with 10070 (w/w) of endoproteinase 
Arg-C (EC 3.4.21.40, Boehringer) in 0.1 M potassium 
phosphate buffer, pH 8.2, 0.25 M (NH4)2SO+, 2 mM glycine 
for 15 h at 370C. The digest was eparated on the Bio Gel 
Phenyl-5PW column. 
Cyanogen bromide cleavage of chicken cystatin (Ser-form 1) 
was performed with a 200-fold molar excess of CNBr (Serva) in 
70070 formic acid for 15 h at 25°C. The cleavage products were 
separated by FPLC on a Superose 12 column (Pharmacia) in 
507o (v/v) formic acid (0.2 ml/min). 
2.3. Amino acid sequence analysis 
Peptides were sequenced by automated solid-phase Edman 
degradation i  a non-commercial instrument [11], or, after 
desalting on a reverse phase C-8 column, in a Knauer sequencer 
model 810 [12]. 
2.4. Determination of  inhibition constants 
The inhibition constants Ki of the complexes with papain 
were determined in stopped fluorometric assays as described 
[13]. The active concentrations of inhibitory peptides were 
determined by titration with papain. Inhibition of papain was 
measured at equilibrium with a set of different concentrations 
of the inhibitor (usually 10 or more), and Ki was calculated by 
nonlinear egression analysis using the general equation for 
tight-binding inhibition [14] in the computer program ENZFIT- 
TER (Elsevier-BIOSOFT, Cambridge, England). 
3. RESULTS 
3.1. N-terminally truncated forms 
Ion exchange chromatography of crude chicken 
egg white cystatin on M~no Q resulted in two ma- 
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Fig.l. Hydrophobic interaction chromatography of chicken 
cystatin. (A) Separation of isoelectric form 1 (pI = 6.5) into N- 
terminally truncated isoforms eluting in the order Gly-form, 
Ala-form, Ser-form and Leu-form (see table 1 for explanation 
of nomenclature). (B) Separation of a mixture of isoelectric 
forms 1 (pl = 6.5) and 2 (pl = 5.6) into the N-terminally 
truncated Gly- and Ser-forms. 
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Table 1 
Inhibition of papain by N-terminally truncated forms of chicken cystatin 
Form N-terminal sequence Ki ± SD a (nM) 
Ser-form 1 
Ser-form 2 
Leu-form 1 
Gly-form 1 
Gly-fdrm 2 
Ala-form 2 
5 10 15 
S EDRS RL LGAPVPVDEND. . .  0.006+0.0001 
S E DRS RL  LGAP VP  VDE ND. . .  0.007 + 0.0003 
LLGAPVPVDEND. . .  0.006±0.0003 
GAPVPVDEND. . .  26.6 ±3.2 
GAPVPVDEND. . .  33.9 ±2.2 
APVPVDEND. . .  31.6 ±2.6 
a Standard eviation of Ki obtained by nonlinear regression analysis 
Truncated forms of the inhibitor are named according to their N-terminal amino 
acid residue followed by a number indicating their o igin from isoelectric form 1 
(pI = 6.5) or 2 (pI = 5.6) 
jor peaks eluting at0.07 M KC1 (form 1, pI = 6.5) 
and 0.14 M KCI (form 2, pI = 5.6). Material from 
both peaks was heterogeneous in isoelectric focus- 
ing. Homogeneous i oforms were obtained by 
subsequent hydrophobic nteraction chromatogra- 
phy (fig.lA). Up to four different forms were 
separated from both isoelectric forms 1 and 2. The 
separated forms were identified by sequence 
analysis as Gly-, Ala-, Ser- and Leu-form accor- 
ding to their N-terminal amino acid residue (table 
1). The Gly- and Ser-forms were the most promi- 
nent isoforms whereas the Ala- and Leu-forms 
were usually present in minor amounts. In some 
batches the Ala-forms were missing. Sequencing 
over at least 10 steps revealed no differences be- 
tween Gly-form 1 and 2 or Set-form 1 and 2, 
"respectively (see table 1 for explanation of 
nomenclature). All four forms could be separated 
by hydrophobic interaction chromatography 
(fig.lB) and non-denaturing PAGE (not shown), 
suggesting that sequence differences between the 
isoelectric forms with the same amino terminus 
could exist and should be located behind position 
18 of full-length cystatin. 
Treatment of native Ser-form 1 with endopro- 
teinase Arg-C resulted in selective and almost 
quantitative cleavage of the Arg-6-Leu-7-bond. 
The resulting Leu-form 1 was isolated by 
hydrophobic nteraction chromatography. 
Titration of papain indicated that 62-75°70 of 
the isolated forms (quantitated bytheir absorbance 
at 280 nm) were inhibitorily active after the 
purification procedure. Inhibition constants (Ki) 
for papain (see table 1) of full-length Ser-form 1 
and Ser-form 2 were virtually identical and com- 
parable to those previously reported of native 
chicken cystatin (Ki < 0.005 nM [3]). The trun- 
cated Leu-form 1 had virtually the same Ki for pa- 
pain as full-length chicken cystatin (fig.2), whereas 
the truncated Gly-form 1, Gly-form 2 and Ala- 
form 2 had a -5000-fold lower affinity for this 
proteinase. 
3.2. Cyanogen bromide fragments 
Cyanogen bromide cleavage of full-length 
chicken cystatin (Ser-form 1) followed by FPLC 
on a Superose 12 gel filtration column resulted in 
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Fig.2. Inhibition of papain (12 pM) by different concentrations 
of Set-form 1 (~. ;), Ser-form 2 (A.--A) and Leu-form 1 
(o---o) of chicken cystatin. The fractional activity is the 
reaction rate in the presence of inhibitor divided by the rate in 
its absence. The curves were calculated from the general 
equation for tight-binding inhibition [14] using the Ki values 
determined from the experimental data shown here (cf. table 1). 
236 
Volume 243, number 2 FEBS LETTERS January 1989 
two peaks (not shown). As revealed by N-terminal 
sequence analysis, the first peak contained the in- 
termediate fragment (CN-2, residues 30-89), the 
second peak a mixture of the N-terminal fragment 
(CN-1, residues (1-29) and the C-terminal frag- 
ment (CN-3, residues 90-116) [4]. Only the in- 
termediate fragment (CN-2) inhibited papain 
weakly with a Ki of 900 nM, compared to a Ki of 
10 pM for the uncleaved inhibitor which had been 
subjected to the same acidic conditions as in 
cyanogen bromide cleavage and chromatographed 
on the same column in a control experiment. The 
mixture of CN-1 and CN-3 showed no inhibitory 
activity. 
4. DISCUSSION 
Sequence comparisons of cystatins provided in- 
direct evidence that the conserved QVVAG se- 
quence motif might be essential for their inhibitory 
activity [15,16]. This is consistent with our docking 
model of a chicken cystatin-papain complex where 
the most intimate contacts are made through the 
main and side chain groups of the analogous 
chicken cystatin QLVSG segment with parts of the 
putative S1-subsite of papain [8]. In the N-terminal 
part of cystatins, a glycine residue corresponding 
to Gly-9 of chicken cystatin is conserved in all in- 
hibitorily active members of the superfamily [1,2]. 
According to the docking model, Gly-9 is in the 
close vicinity of but not in direct contact with the 
active site Cys-25 of papain. Within the preceding 
segment, assuming a tight-turn conformation 
(fig.3), the side chain of Leu-8 could bind to the 
S2-subsite which mainly determines the substrate 
specificity of papain [17,18]. Our results obtained 
with N-terminally truncated forms of chicken 
cystatin strongly support this idea. Whereas the 
Leu-form exhibits the same inhibitory activity as 
the full-length Ser-forms, removal of Leu-7 and 
Leu-8 leads to an approximately 5000-fold lower 
affinity for papain. This is in agreement with our 
observation that a truncated form of human 
cystatin C [19] starting with Leu-Val- before the 
conserved Gly-ll (corresponding to Gly-9 of 
chicken cystatin) has virtually the same affinity for 
papain as the full-length form (Ki = 5 pM), 
whereas the truncated form starting with Gly-12 
has been reported to be a more than 1000-fold 
weaker inhibitor [7]. One or two residues 
o op 
116 
IO? 
O6 
Fig.3. Scheme of the proposed model for the interaction of 
chicken cystatin with papain. Explanation in text. 
preceding the conserved Gly seem to be mainly 
responsible for the tighter binding of cystatins to 
papain. Cystatins containing a single residue in 
front of the conserved Gly which are equally active 
as the full-length forms have been found in the 
stefin family [20] and prepared by expression of 
synthetic genes [21,22]. 
The selective binding of the intermediate CNBr 
fragment containing the QLSVG segment isconsis- 
tent with its central role for the papain-inhibitor 
interaction. Its significantly increased affinity 
towards papain compared with short QVVAG- 
related peptides [23] might be due to intra-peptide 
stabilisation within a hairpin loop-like structure 
similar to that observed in intact chicken cystatin 
[8]. The direct relation between affinity and chain 
extension in the N-terminal direction beyond Gly-9 
is in agreement with the additional contribution of 
the elongated N-terminal segment to binding. Of 
great surprise, however, is the stepwise tremendous 
increase of affinity in going from Gly-9 to Leu-8 
and/or Leu-7. In conclusion, the affinity data 
presented here are independent evidence for the 
validity of the docking model. 
237 
Volume 243, number 2 FEBS LETTERS January 1989 
Acknowledgements: The authors wish to thank R. Huber, H. 
Fritz and E.-A. Auerswald for stimulating discussion. The in- 
vestigations were supported by the Sonderforschungsbereich 
207 of the University of Munich (grants G-I and H-l), the 
Bundesministerium fiir Forschung und Technologie (grant PBE 
18855B) and the Research Council of Slovenia. 
REFERENCES 
[1] Barrett, A.J., Rawlings, N.D., Davies, M.E., Machleidt, 
W., Salvesen, G. and Turk, V. (1986) in: Proteinase 
lnhibitors (Barrett, A.J. and Salvesen, G. eds) 
pp.515-569, Elsevier, Amsterdam. 
[2] Barrett, A.J. (1987) Trends Biochem. Sci. 12, 193-196. 
[3] Nicklin, M.J.H. and Barrett, A.J. (1984) Biochem. J. 
223, 245-253. 
[4] Turk, V., Brzin, J., Longer, M., Ritonja, A., Eropkin, 
M., Borchart, U. and Machleidt, W. (1983) Hoppe 
Seyler's Z. Physiol. Chem. 364, 1487-1496. 
[5] Anastasi, A., Brown, M.A., Kembhavi, A.A., Nicklin, 
M.J.H., Sayers, C.A., Sunter, D.C. and Barrett, A.J. 
(1983) Biochem. J. 211, 129-138. 
[6] Schwabe, C., Anastasi, A., Crow, H., McDonald, J.K. 
and Barrett, A.J. (1984) Biochem. J. 217, 813-817. 
[7] Abrahamson, M., Ritonja, A., Brown, M.A., Grubb, A., 
Machleidt, W. and Barrett, A.J. (1987) J. Biol. Chem. 
262, 9688-9694. 
[8] Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., 
Karshikow, A., Brzin, J., Kos, J. and Turk, V. (1988) 
EMBO J. 7, 2593-2599. 
[9] Sluyterman, L.A.E. and Wijdenes, J. (1970) Biochim. 
Biophys. Acta 200, 590-593. 
[10] Barrett, A.J., Khembhavi, A.A., Brown, M.A., 
Kirschke, H., Knight, C.G., Tamai, M. and Hanada, K.
(1982) Biochem. J. 201, 189-198. 
[11] Machleidt, W., Borchart, U. and Ritonja, A. (1986) in: 
Advanced Methods in Protein Microsequence Analysis 
(Wittmann-Liebold, B., Saknikow, J. and Erdmann, 
V.A. eds) pp.91-107. 
[12] Fischer, S., Reimann, F. and Wittmann-Liebold, B.
(1989) in: Methods in Protein Sequence Analysis 
(Wittmann-Liebold, B. ed.) Springer, Berlin, in press. 
[13] Vogel, R., Assfalg-Machleidt, I., Esterl, A., Machleidt, 
W. and Miiller-Esterl, W. (1988) J. Biol. Chem. 263, 
12661-12669. 
[14] Bieth, J.G. (1984) Biochem. Med. 32, 387-397. 
[15] Turk, V,. Brzin, J., Lenarcic, B., Locnikar, P., Popovic, 
T., Ritonja, A., Babnik, J., Bode, W. and Machleidt, W. 
(1985) in: Intracellular Protein Catabolism V (Khairallah, 
E. and Bonds, J. eds) pp.91-103, Alan R. Liss, New 
York. 
[16] Ohkubo, I., Kurachi, K., Takasawa, T., Shiokawa, H. 
and Sasaki, M. (1984) Biochemistry 23, 5691-5697. 
[17] Drenth, J., Kalk, K.H. and Swen, H.M. (1976) 
Biochemistry 15, 3731-3738. 
[18] Asboth, B., Majer, Z. and Polgar, L. (1988) FEBS Lett. 
233, 339-341. 
[19] Brzin, J., Popovic, T., Turk, V., Borchart, U. and 
Machleidt, W. (1984) Biochem. Biophys. Res. Commun. 
118, 103-109. 
[20] Takio, K., Kominami, E., Wakamatsu, N., Katunuma, 
N. and Titani, K. (1983) Biochem. Biophys. Res. Com- 
mun. 115,902-908. 
[21] Thiele, U., Auerswald, E.-A., Gebhard, W., Assfalg- 
Machleidt, I., Popovic, T. and Machleidt, W. (1988) Biol. 
Chem. Hoppe-Seyler 369, 1167-1178. 
[22] Jerala, R., Trstenjak, M., Lenarcic, B. and Turk. V. 
(1988) FEBS Lett. 239, 41-48. 
[23] Teno, N., Tsuboi, S., Itoh, N., Okamoto, H. and Okada, 
Y. (1987) Biochem. Biophys. Res. Commun. 143, 
749-752. 
238 
